BMP-7, a commonly used drug to treat osteoporosis in patients, has been tested in animal models of atherosclerosis and found to have anti-inflammatory and anti-fibrotic properties in the heart, muscle, and kidney [52]. This evidence concerns the gene BMP7 and atherosclerosis.